Neurolixis

Neurolixis Inc is an early-stage biopharmaceutical company focused on the discovery and development of novel drugs for the treatment of human central nervous system disorders including Parkinson's disease, Rett syndrome, depression and schizophrenia.

Focus area
Neuroscience
Commencement date
02/01/2012